Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Biological and biochemical properties of Ret with kinase domain mutations identified in multiple endocrine neoplasia type 2B and familial medullary thyroid carcinoma.

Iwashita T, Kato M, Murakami H, Asai N, Ishiguro Y, Ito S, Iwata Y, Kawai K, Asai M, Kurokawa K, Kajita H, Takahashi M.

Oncogene. 1999 Jul 1;18(26):3919-22.

2.

RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.

Marsh DJ, Mulligan LM, Eng C.

Horm Res. 1997;47(4-6):168-78. Review.

PMID:
9167949
3.
4.

RET protooncogene mutational analysis in multiple endocrine neoplasia syndrome type 2B: case report and review of the literature.

Kahn MA, Cote GJ, Gagel RF.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996 Sep;82(3):288-94. Review.

PMID:
8884827
5.

Oncogenic activation of the ret protooncogene in thyroid cancer.

Takahashi M.

Crit Rev Oncog. 1995;6(1):35-46. Review.

PMID:
8573606
7.

Putting the bits and pieces of the RET proto-oncogene puzzle together.

Gagel RF.

Bone. 1995 Aug;17(2 Suppl):13S-16S. Review.

PMID:
8579892
9.

[Neural crest and multiple endocrinopathies].

Pasini A, Michiels FM, Chappuis-Flament S, Geneste O, Rossel M, Fournier L, Feunteun J, Lenoir G, Schuffenecker I, Billaud M.

C R Seances Soc Biol Fil. 1996;190(5-6):557-67. Review. French.

PMID:
9074721
10.

Multiple endocrine neoplasia type 2.

Forster-Gibson CJ, Mulligan LM.

Eur J Cancer. 1994;30A(13):1969-74. Review. No abstract available.

PMID:
7734209
11.

Medullary thyroid carcinoma and multiple endocrine neoplasia type 2.

Takami H.

Endocr Pathol. 2003 Summer;14(2):123-31. Review.

PMID:
12858002
12.

RET gene and its implications for cancer.

Goodfellow PJ, Wells SA Jr.

J Natl Cancer Inst. 1995 Oct 18;87(20):1515-23. Review.

PMID:
7563185
13.

[Medullary thyroid gland carcinoma. Sporadic/familial. Screening when and why?].

Frilling A, Liedke MO.

Internist (Berl). 1998 Jun;39(6):588-91. Review. German. No abstract available.

PMID:
9677514
14.

Multiple endocrine neoplasia syndromes revisited. Clinical, morphologic, and molecular features.

DeLellis RA.

Lab Invest. 1995 May;72(5):494-505. Review. No abstract available.

PMID:
7745945
15.

Familial neuroendocrine tumors as a model of hereditary cancer.

Anderson RJ, Lynch HT.

Curr Opin Oncol. 1997 Jan;9(1):45-54. Review.

PMID:
9090493
16.

Molecular biology of the MEN2 gene.

Santoro M, Melillo RM, Carlomagno F, Visconti R, De Vita G, Salvatore G, Lupoli G, Fusco A, Vecchio G.

J Intern Med. 1998 Jun;243(6):505-8. Review.

17.

Multiple endocrine neoplasia type 2B--genetic basis and clinical expression.

Lee NC, Norton JA.

Surg Oncol. 2000 Nov;9(3):111-8. Review.

PMID:
11356339
18.

Different mutations of the RET gene cause different human tumoral diseases.

Santoro M, Melillo RM, Carlomagno F, Visconti R, De Vita G, Salvatore G, Fusco A, Vecchio G.

Biochimie. 1999 Apr;81(4):397-402. Review.

PMID:
10401675
19.

Genetic basis of endocrine disease: multiple endocrine neoplasia type 2.

Mulligan LM, Ponder BA.

J Clin Endocrinol Metab. 1995 Jul;80(7):1989-95. Review. No abstract available.

PMID:
7608246
20.

Genetic aspects of familial thyroid cancer.

Morrison PJ, Atkinson AB.

Oncologist. 2009 Jun;14(6):571-7. doi: 10.1634/theoncologist.2009-0046. Epub 2009 May 22. Review.

Supplemental Content

Support Center